Search the Newsreel

Annexon (ANNX) filer Thomas Wiggans eyes 2,000-share NASDAQ stock sale

Thomas Wiggans, a shareholder in Annexon (ANNX), has filed a notice for the proposed sale of 2,000 common shares via Fidelity Brokerage Services LLC on NASDAQ, with an indicated value of $12,630.01. This planned sale follows a previous sale of 1,000 common shares by …

ANNX Maintained by Needham -- Price Target Raised to $25

Needham analyst Joseph Stringer maintained a 'Buy' rating on Annexon (ANNX) and significantly raised the price target from $11.00 to $25.00, reflecting strong confidence in the company's growth potential. Despite a low GF Score of 34/100, primarily due to profitability challenges, the company shows …

Annexon to present data on vonaprument for macular degeneration By Investing.com

Annexon Inc. is set to present Phase 2 ARCHER trial data on its drug candidate, vonaprument, for geographic atrophy at the American Society of Retina Specialists 44th Annual Scientific Meeting. This data will inform patient selection for the ongoing Phase 3 ARCHER II trial, …

Flexopack Societe Anonyme Commercial and Industrial Plastics : ANNOUNCEMENT OF REGULATED INFORMATION - TRANSACTIONS NOTIFICATION

Sodexo bondit de près de 10 % après ses résultats : redressement ou emballement ?

Sodexo: Prévisions et Estimations des Analystes | SW

Exor N.V.: koersdoel en analistenconsensus | EXO | NL0012059018

Le prix de l'action Sodexo SA (SW.PA) : Actualités et prévisions des analystes